Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterisation of a type II functionally-deficient variant of alpha-1-antitrypsin discovered in the general population

11 Jan 2019

Abstract excerpt

Lung disease in alpha-1-antitrypsin deficiency (AATD) results from dysregulated proteolytic activity, mainly by neutrophil elastase (HNE), in the lung parenchyma. This is the result of a substantial reduction of circulating alpha-1-antitrypsin (AAT) and the presence in the plasma of inactive polymers of AAT. Moreover, some AAT mutants have reduced intrinsic activity toward HNE, as demonstrated for the common Z...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Coagulation and Thrombosis Mechanisms
Share to Peptidase Inhibition and Analysis
Share to Protease and Inhibitor Mechanisms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30633749
DOI: 10.1371/journal.pone.0206955

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 18 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterisation of a type II functionally-deficient variant of alpha-1-antitrypsin discovered in the general populationPMID 30633749Read ↗

Characterisation of a type II functionally-deficient variant of alpha-1-antitrypsin discovered in the general populationSemantic proximity Read ↗

Probing of the reactive center loop region of alpha-1-antitrypsin by mutagenesis predicts new type-2 dysfunctional variants.Semantic proximity Read ↗

Functional and clinical significance of novel SERPINA1 variants on alpha-1 antitrypsin deficiency.Semantic proximity Read ↗

Functional and structural impact of novel SERPINA1 variants on Alpha-1 Antitrypsin DeficiencySemantic proximity Read ↗

Known Mutations at the Cause of Alpha-1 Antitrypsin Deficiency an Updated Overview of SERPINA1 Variation SpectrumSemantic proximity Read ↗

Understanding alpha-1 antitrypsin deficiency: A review with an allergist's outlookSemantic proximity Read ↗

Alpha-1 Antitrypsin Deficiency: Current Landscape of Detection, Management, and Treatment.Semantic proximity Read ↗

The discovery of α1-antitrypsin and its role in health and disease.Semantic proximity Read ↗

The emerging role of proteases in α1-antitrypsin deficiency and beyondSemantic proximity Read ↗

Comprehensive Clinical Diagnostic Pipelines Reveal New Variants in Alpha-1 Antitrypsin Deficiency.Semantic proximity Read ↗

The European Alpha-1 Research Collaboration (EARCO): a new ERS Clinical Research Collaboration to promote research in alpha-1 antitrypsin deficiencySemantic proximity Read ↗

Alpha-1-antitrypsin deficiency: Genetic variations, clinical manifestations and therapeutic interventions.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.